- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.01. | China's NMPA approves Astellas' advanced gastric cancer combo therapy | ||
| 03.01. | China's NMPA approves Innovent's taletrectinib for NSCLC treatment | ||
| 02.01. | Brii Biosciences acquires BRII-179 assets from VBI Vaccines | ||
| 31.12.24 | WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery | ||
| 30.12.24 | FDA approves BeiGene's TEVIMBRA combo for treating certain gastric cancers | ||
| 27.12.24 | Axcelead DDP and Astellas partner for targeted protein degrader discovery | ||
| 26.12.24 | Bio-Thera and Tabuk partner for Stelara biosimilar in Saudi Arabia | ||
| 24.12.24 | Basilea receives additional funding from CARB-X to advance antibiotic candidate | ||
| 23.12.24 | WuXi Biologics and Hangzhou DAC sign ADC agreement | ||
| 20.12.24 | Assembly Bio and Gilead collaborate to advance antiviral therapeutic programmes | ||
| 19.12.24 | Agios announces EC's positive decision for sickle cell disease therapy designation | ||
| 18.12.24 | Akamis secures funds to advance cancer therapy through study | ||
| 17.12.24 | Candid partners with EpimAb to develop T-cell engager candidates | ||
| 16.12.24 | Sanofi's multiple sclerosis therapy gains breakthrough therapy status from FDA | ||
| 13.12.24 | Tanner-Agenus partner for expanded access to immunotherapies for cancer patients | ||
| 12.12.24 | ProQR expands partnership with RSRT to advance Rett Syndrome therapy | ||
| 11.12.24 | Orthogon secures funding to boost BK virus treatments for transplant patients | ||
| 10.12.24 | FDA accepts Crinetics Pharmaceuticals' NDA for acromegaly treatment therapy | ||
| 09.12.24 | Torii submits NDA for molluscum contagiosum treatment therapy in Japan | ||
| 06.12.24 | MindMed receives innovation passport for GAD therapy from UK MHRA | ||
| 05.12.24 | Theratechnologies to license Ionis' RNA-targeted therapies in Canada | ||
| 04.12.24 | Gilead and Tubulis sign ADC development deal for cancer treatment | ||
| 03.12.24 | Japan MHLW grants orphan drug status to Renalys' sparsentan for IgAN treatment | ||
| 02.12.24 | Hong Kong regulator accepts Everest's ulcerative colitis therapy NDA | ||
| 29.11.24 | Dr. Reddy's Laboratories introduces Toripalimab in India for nasopharyngeal carcinoma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
